However, in the Stroke + Mexidol group, the numbers of neurons with high and medium nuclear PGC-1α immunoreactivity were higher by 40% and 30% (p < 0.05), respectively, and those in the Stroke + Semax group were higher by 25% and 20% (p < 0.05) in comparison to the Stroke + Saline group (Figure 7A,B, Figures S29 and S30). This evidence concerns the gene PPARGC1A and Stroke.